Description

Chemical Properties

Description

Tirzepatide is a dual-action agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, amplifying the effects of both incretin hormones simultaneously. This dual mechanism enhances insulin secretion, reduces glucagon levels, and improves glucose regulation more effectively than single-pathway agonists. Tirzepatide is being actively studied for its role in type 2 diabetes management, weight regulation, and broader metabolic health outcomes.